Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 7/1999

01-07-1999

Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells

Authors: Julian Carretero, Elena Obrador, Miren J. Anasagasti, Javier J. Martin, Fernando Vidal-Vanaclocha, José M. Estrela

Published in: Clinical & Experimental Metastasis | Issue 7/1999

Login to get access
Metadata
Title
Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells
Authors
Julian Carretero
Elena Obrador
Miren J. Anasagasti
Javier J. Martin
Fernando Vidal-Vanaclocha
José M. Estrela
Publication date
01-07-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 7/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006725226078

Other articles of this Issue 7/1999

Clinical & Experimental Metastasis 7/1999 Go to the issue

OriginalPaper

Significance of VLA-4–VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model

OriginalPaper

Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer

OriginalPaper

Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands

OriginalPaper

bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer

OriginalPaper

Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan

OriginalPaper

Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits